Djurslands Bank (DJUR)
Nasdaq Copenhagen · Denmark · prices in DKK · close of 27 Oct 2026
Key indicators
| Last close | DKK 1,105.00 |
|---|---|
| 52-week range | 758.00 – 1,185.00 |
| Return, 1 month / 3 months | −0.9% / +5.7% |
| Return, 1 year / 3 years | +43.9% / +174.4% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 29.9% |
| Worst drawdown (1 year) | -24.9% |
| Average daily value traded | 1.78M DKK |
| Dividend yield | 1.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Djurslands Bank is a Danish local bank serving private customers and small businesses in the Djursland region of Jutland. It offers everyday banking such as deposit accounts, loans, mortgages and card services, along with advice for personal finances and small business needs. The bank operates through its local branch network and is based in Denmark, with its roots in the Djursland area it serves.
On this site Djurslands Bank appears as a stock on the Nasdaq Copenhagen (Denmark), code DJUR, with prices in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Djurslands Bank (DJUR) trades on the Nasdaq Copenhagen in Denmark. It last closed at DKK 1,105.00 on 27 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 54 of 164 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 43.9% and over the last three months it rose 5.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Copenhagen
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.7% | ||
| From 52-week high | -5.6% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 5.7% | ||
| 6-month return | 19.3% | ||
| 12-month return, skipping the last month | 45.2% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.9% | ||
| Liquidity | 62 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.78M DKK | ||
| Zero-volume days | 0.0% | ||
| Income | 48 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.8% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.3% |
|---|---|
| 1 month | −0.9% |
| 3 months | +5.7% |
| 6 months | +19.3% |
| 1 year | +43.9% |
| 3 years | +174.4% |
| 5 years | +268.2% |
Signals
| 50-day / 200-day average | 1,076.90 / 1,007.65 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 23.10 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Mar 2026 | DKK 20.0000 |
| 19 Mar 2025 | DKK 30.0000 |
| 20 Mar 2024 | DKK 30.0000 |
| 16 Mar 2023 | DKK 10.0000 |
| 17 Mar 2022 | DKK 8.5000 |
| 12 Mar 2020 | DKK 8.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Copenhagen; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.